IR

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Financial Information

80,000 60,000 40,000 20,000 0 -20,000
80,000 60,000 40,000 20,000 0 -20,000

202158,256

202245,857

2023 63,922

Total assets

80,000 60,000 40,000 20,000 0 -20,000

2021 19,496

2022 23,419

2023 23,427

Total liabilities

80,000 60,000 40,000 20,000 0 -20,000

2021 38,761

2022 22,439

2023 40,495

Total capitals

80,000 60,000 40,000 20,000 0 -20,000

2021 -13,071

2022 -22,865

2023 -11,611

Operating profit

  • 2021
  • 2022
  • 2023

Balance sheet (unit : 1 million won)Scroll left and right to read.

Item 2021 2022 2023
Current Assets 20,808 20,978 16,874
Non-Current Assets 37,448 24,880 47,048
Total Assets 58,256 45,857 63,922
Current Liabilities 1,846 20,539 10,325
Non-Current Liabilities 17,649 2,879 13,102
Total Liabilities 19,496 23,419 23,427
Capital 4,866 4,866 6,801
Retained Earnings -19,519 -41,036 -52,696
Total Equity 38,761 22,439 40,495

Income statement (unit : 1 million won)Scroll left and right to read.

Item 2021 2022 2023
Sales 909 480 0
Operating Profit -13,011 -14,911 -12,198
Profit before Income Tax -13,071 -22,865 -11,611
Net Profit -13,071 -22,865 -11,611
-13,071 -22,865 -11,611
0 0 314